Photo: academy.eahad.org
May 1, 2026, 13:23
Key Advances Across the Full Spectrum of VWD at EAHAD 2025
European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:
”A century of progress in von Willebrand Disease continues to shape how we diagnose, understand, and treat patients today.
At EAHAD 2025, this session featured Carlo Castaman, Omid Seidizadeh, and Jeroen Eikenboom to explore key advances across the full spectrum of VWD.
Missed the live session? Relive the insights anytime on EAHAD Academy.”
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared this post on LinkedIn, adding:
”It was my pleasure to be invited to contribute to this EAHAD session on von Willebrand Disease.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention